tradingkey.logo

tradingkey.logo
怜玢


Stereotaxis Inc

STXS
りォッチリストに远加
1.850USD
-0.085-4.38%
終倀 05/15, 16:00ET15分遅れの株䟡
180.81M時䟡総額
損倱額盎近12ヶ月PER


詳现情報 Stereotaxis Inc 䌁業名

Stereotaxis, Inc. designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory. Its proprietary robotic technology, Robotic Magnetic Navigation (RMN), fundamentally transforms endovascular interventions using precise computer-controlled magnetic fields to directly control the tip of flexible interventional catheters or devices. The Company’s primary products include the Genesis RMN System, the Odyssey Solution, and other related devices. Through its strategic relationships with fluoroscopy system manufacturers, providers of catheters and electrophysiology mapping systems, and other parties, the Company offers its customers x-ray systems and other accessory devices. The Genesis RMN System is designed to enable physicians to complete more complex interventional procedures by providing image-guided delivery of catheters through the blood vessels and chambers of the heart to treatment sites.

Stereotaxis Incの䌁業情報


䌁業コヌドSTXS
䌚瀟名Stereotaxis Inc
䞊堎日Aug 12, 2004
最高経営責任者「CEO」Fischel (David Leo)
埓業員数139
蚌刞皮類Ordinary Share
決算期末Aug 12
本瀟所圚地710 N Tucker Blvd
郜垂ST. LOUIS
蚌刞取匕所NASDAQ OMX – NASDAQ Basic Amex
囜United States of America
郵䟿番号63101
電話番号13146786100
りェブサむトhttps://www.stereotaxis.com/
䌁業コヌドSTXS
䞊堎日Aug 12, 2004
最高経営責任者「CEO」Fischel (David Leo)

Stereotaxis Incの経営陣


䌚瀟名
䌚瀟名/ポゞション
ポゞション
株匏保有
倉動額
Mr. David W. Benfer
Mr. David W. Benfer
Lead Independent Director
Lead Independent Director
463.30K
-19.56%
Mr. David Leo Fischel
Mr. David Leo Fischel
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
255.00K
+21.57%
Dr. Nathan Fischel, M.D.
Dr. Nathan Fischel, M.D.
Director
Director
254.50K
-12.03%
Mr. Ross B. Levin
Mr. Ross B. Levin
Independent Director
Independent Director
154.97K
-19.76%
Mr. Nachum (Homi) Shamir
Mr. Nachum (Homi) Shamir
Director
Director
136.22K
+34.46%
Dr. Arun Swarup Menawat, Ph.D.
Dr. Arun Swarup Menawat, Ph.D.
Independent Director
Independent Director
--
--
Ms. Kimberly R. Peery
Ms. Kimberly R. Peery
Chief Financial Officer
Chief Financial Officer
--
--
Dr. Myriam J. Curet, M.D.
Dr. Myriam J. Curet, M.D.
Independent Director
Independent Director
--
--
䌚瀟名
䌚瀟名/ポゞション
ポゞション
株匏保有
倉動額
Mr. David W. Benfer
Mr. David W. Benfer
Lead Independent Director
Lead Independent Director
463.30K
-19.56%
Mr. David Leo Fischel
Mr. David Leo Fischel
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
255.00K
+21.57%
Dr. Nathan Fischel, M.D.
Dr. Nathan Fischel, M.D.
Director
Director
254.50K
-12.03%
Mr. Ross B. Levin
Mr. Ross B. Levin
Independent Director
Independent Director
154.97K
-19.76%
Mr. Nachum (Homi) Shamir
Mr. Nachum (Homi) Shamir
Director
Director
136.22K
+34.46%
Dr. Arun Swarup Menawat, Ph.D.
Dr. Arun Swarup Menawat, Ph.D.
Independent Director
Independent Director
--
--

収益内蚳

通貚: USD曎新時刻: Mon, Apr 6
通貚: USD曎新時刻: Mon, Apr 6
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
䌚瀟から関連デヌタがただ開瀺されおいたせん。
地域別USD
䌚瀟名
収益
比率
International
19.51M
60.26%
United States
12.87M
39.74%
事業別
地域別
䌚瀟から関連デヌタがただ開瀺されおいたせん。

株䞻

曎新時刻: Sun, May 10
曎新時刻: Sun, May 10
株䞻統蚈
皮類
株䞻統蚈
株䞻統蚈
比率
Dafna Capital Management, LLC
14.03%
Kiani (Joe E)
10.37%
Lagoda Investment Management, L.P.
4.99%
BlackRock Institutional Trust Company, N.A.
3.82%
2012 Revocable Trust of Andrew Redleaf
3.16%
他の
63.64%
株䞻統蚈
株䞻統蚈
比率
Dafna Capital Management, LLC
14.03%
Kiani (Joe E)
10.37%
Lagoda Investment Management, L.P.
4.99%
BlackRock Institutional Trust Company, N.A.
3.82%
2012 Revocable Trust of Andrew Redleaf
3.16%
他の
63.64%
皮類
株䞻統蚈
比率
Investment Advisor
17.49%
Hedge Fund
17.31%
Individual Investor
14.77%
Investment Advisor/Hedge Fund
11.28%
Corporation
3.16%
Bank and Trust
0.65%
Research Firm
0.50%
Pension Fund
0.01%
他の
34.84%

機関投資家保有株


曎新時刻: Wed, Apr 1
曎新時刻: Wed, Apr 1
報告期間
機関投資家数
保有株匏数
比率
倉動額
2026Q1
205
49.70M
50.99%
+2.24M
2025Q4
186
43.95M
47.09%
-1.61M
2025Q3
175
41.68M
45.77%
-4.01M
2025Q2
184
70.71M
77.86%
+13.38M
2025Q1
192
70.55M
82.04%
+9.72M
2024Q4
185
55.40M
64.94%
-4.27M
2024Q3
178
54.77M
64.71%
-4.91M
2024Q2
173
55.07M
66.24%
-4.36M
2024Q1
185
55.40M
67.15%
-4.49M
2023Q4
184
51.49M
64.77%
-9.27M
詳现を芋る

株䞻動向


䌚瀟名
保有株匏数
比率
倉動額
倉動率
日付
Dafna Capital Management, LLC
13.68M
14.07%
--
--
Dec 31, 2025
Kiani (Joe E)
8.86M
9.11%
+427.40K
+5.07%
Mar 17, 2025
Lagoda Investment Management, L.P.
4.86M
5%
+153.80K
+3.27%
Dec 31, 2025
BlackRock Institutional Trust Company, N.A.
3.73M
3.83%
+44.20K
+1.20%
Dec 31, 2025
2012 Revocable Trust of Andrew Redleaf
3.08M
3.16%
--
--
Mar 17, 2025
Arbiter Partners Capital Management, LLC
2.88M
2.97%
+30.00K
+1.05%
Dec 31, 2025
Isaac (Paul J)
2.06M
2.12%
+10.00K
+0.49%
Nov 17, 2025
Essex Investment Management Company, LLC
1.56M
1.61%
-36.09K
-2.26%
Dec 31, 2025
Geode Capital Management, L.L.C.
1.57M
1.61%
+55.49K
+3.68%
Dec 31, 2025
詳现を芋る

関連ETF


曎新時刻: Sat, Dec 6
曎新時刻: Sat, Dec 6
銘柄名
比率
iShares Micro-Cap ETF
0.03%
Global X Russell 2000 ETF
0.01%
Proshares Ultra Russell 2000
0.01%
ProShares UltraPro Russell2000
0.01%
ProShares Hedge Replication ETF
0.01%
iShares Russell 2000 Growth ETF
0.01%
iShares Russell 2000 Value ETF
0%
iShares Russell 2000 ETF
0%
iShares Micro-Cap ETF
比率0.03%
Global X Russell 2000 ETF
比率0.01%
Proshares Ultra Russell 2000
比率0.01%
ProShares UltraPro Russell2000
比率0.01%
ProShares Hedge Replication ETF
比率0.01%
iShares Russell 2000 Growth ETF
比率0.01%
iShares Russell 2000 Value ETF
比率0%
iShares Russell 2000 ETF
比率0%

配圓金


過去5幎間の配圓金総支払額は 0.00 米ドルである。
日付
配圓金
暩利確定日
支払日
配圓萜ち日
デヌタなし

株匏分割


日付
配圓萜ち日
皮類
比率
デヌタなし
日付
配圓萜ち日
皮類
比率
デヌタなし
KeyAI
î™